iCeutica is developing a pipeline of reformulated and improved products. In addition they work with their pharmaceutical partners to utilize the SoluMatrix platform to improve generics or late stage NCE's. They also extend the life cycle of selected marketed products by introducing new formulations, combining these products with other drugs or creating new delivery methods, all of which are coupled with renewed patent protection and FDA exclusivity periods.